Showing 2,641 - 2,647 results of 2,647 for search '(( significantly greater decrease ) OR ( significantly impairs decrease ))', query time: 0.32s Refine Results
  1. 2641

    Ubiquitin degradation of the Ribonuclease H2 subunit B Rnh2B regulates the virulence of <i>Cryptococcus neoformans</i> by Meng-Ru Guo (21375491)

    Published 2025
    “…Research has shown that the absence of Cdc4, an F-box protein in <i>C. neoformans</i>, decreases virulence, yet the mechanisms by which Cdc4 affects these processes remain unclear. …”
  2. 2642

    Image1_Dexamethasone and IFN-γ primed mesenchymal stem cells conditioned media immunomodulates aberrant NETosis in SLE via PGE2 and IDO.tiff by Khushbu Priya (11863559)

    Published 2024
    “…Both excessive NET formation and impaired degradation contribute to SLE pathophysiology.…”
  3. 2643

    Data Sheet 1_Top motor and non-motor complaints in patients with Parkinson's disease.docx by José Fidel Baizabal-Carvallo (11416508)

    Published 2025
    “…Cognitive impairment was a significant predictor of non-motor symptoms in their top three tiers [odds ratio [OR]: 3.88 (95% CI: 1.647 to 9.169)]. …”
  4. 2644

    Image3_Dexamethasone and IFN-γ primed mesenchymal stem cells conditioned media immunomodulates aberrant NETosis in SLE via PGE2 and IDO.tif by Khushbu Priya (11863559)

    Published 2024
    “…Both excessive NET formation and impaired degradation contribute to SLE pathophysiology.…”
  5. 2645

    Image2_Dexamethasone and IFN-γ primed mesenchymal stem cells conditioned media immunomodulates aberrant NETosis in SLE via PGE2 and IDO.tif by Khushbu Priya (11863559)

    Published 2024
    “…Both excessive NET formation and impaired degradation contribute to SLE pathophysiology.…”
  6. 2646

    Preliminary efficacy of eye movement desensitization and reprocessing for children aged 1.5–8 years with PTSD: a multiple baseline experimental design (<i>N</i> = 19) by Carlijn de Roos (8061239)

    Published 2025
    “…These symptoms can cause severe impairment to a child’s functioning and, if left untreated, have negative long-term consequences. …”
  7. 2647

    Supporting data for “Androgen receptor modulates chemotherapy response in breast cancer” by Chanping You (9067448)

    Published 2025
    “…For palbociclib, a CDK4/6 inhibitor, AR activation induced RB1 polyubiquitination and degradation, diminishing RB1 levels—a key downstream target of CDK4/6—and thus impairing palbociclib efficacy. Chromatin immunoprecipitation (ChIP) sequencing identified 1,209 AR-regulated genes, with gene ontology (GO) analysis highlighting significant enrichment of ubiquitin-related genes. qPCR validation pinpointed TRIM37, an AR-regulated E3 ligase, as a mediator of RB1 degradation. …”